India's Silent Killer: Vaccines Versus Superbugs

India is confronting a severe public health crisis as antibiotic resistance leads to more deaths than anywhere else globally. Drug-resistant infections directly caused hundreds of thousands of fatalities in 2021, with millions more associated deaths. While standard responses focus on restricting antibiotic use, a vital third strategy, vaccination, remains underutilized.

Preventing infections through vaccines directly reduces the need for antibiotics, thereby combating the rise of untreatable bacteria. Optimal vaccine use could avert billions of antibiotic doses annually. Despite bearing a significant global burden of antibiotic resistance, India has lagged in implementing vaccination strategies to tackle this issue.

Typhoid and pneumococcal pneumonia, increasingly resistant to treatments, highlight this urgent need. While India has licensed typhoid conjugate vaccines and introduced pneumococcal vaccines for children, adult vaccination remains scarce. Expanding vaccination programs for these diseases, alongside influenza, could intercept millions of unnecessary antibiotic prescriptions yearly.

India possesses the manufacturing and infrastructure capacity to expand vaccination. However, political will is crucial to prioritize vaccination not just for child health, but as a core national strategy against antibiotic resistance.